V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10436069 | 10033100 | 1.68 | 75.4 | null | 2022-02-11 | 2022-02-11 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100410675 |
| 10436072 | 10033101 | 1.55 | 73 | null | 2021-08-11 | 2021-09-08 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101860675 |
| 10436078 | 10033102 | 1.67 | 50 | null | 2021-01-11 | 2021-10-19 | Capecitabine | 02 | null | CAPECITABINE | 101371283 |
| 10436088 | 10033103 | 0 | 70.65 | Curative (C) | null | 2017-02-01 | Rituximab | 02 | N | RITUXIMAB | 100540299 |
| 10436091 | 10033104 | 1.65 | 79 | 03 | 2017-01-16 | 2017-01-22 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101252535 |
| 10436095 | 10033105 | 1.57 | 86.5 | Palliative (P) | 2018-07-15 | 2018-07-30 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100390958 |
| 10436102 | 10033106 | 1.85 | 0 | null | 2021-01-14 | 2021-01-14 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 100345850 |
| 10436107 | 10033107 | 1.51 | 86 | null | 2016-07-18 | 2016-07-18 | Rituximab | 02 | null | RITUXIMAB | 101823874 |
| 10436111 | 10033108 | 1.62 | 110.6 | Palliative (P) | 2018-02-19 | 2018-02-26 | Rituximab (Maintenance) | N | N | RITUXIMAB | 101000220 |
| 10436112 | 10033109 | null | 88.7 | 03 | 2017-12-13 | 2017-12-15 | Rituximab | 02 | null | RITUXIMAB | 100962179 |
| 10436116 | 10033110 | 1.6 | 54.7 | null | 2019-04-23 | 2019-05-20 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100645936 |
| 10436129 | 10033111 | 1.78 | 72 | null | 2020-09-15 | 2020-09-15 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100484212 |
| 10436147 | 10033112 | 1.7 | 74.6 | Curative (C) | 2018-07-28 | 2018-07-31 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101736869 |
| 10436148 | 10033113 | 1.69 | 45.2 | Palliative (P) | 2017-06-30 | 2017-07-13 | Capecitabine | 02 | N | CAPECITABINE | 101855138 |
| 10436154 | 10033114 | null | 67.8 | null | 2021-11-19 | 2021-12-02 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 100763660 |
| 10436158 | 10033115 | 1.68 | 108.5 | Neo-adjuvant (N) | 2017-12-10 | 2018-01-03 | PEMBROLIZUMAB | 02 | Y | PEMBROLIZUMAB | 101555579 |
| 10436179 | 10033116 | 1.63 | 62 | null | 2014-04-30 | 2014-05-07 | IBRUTINIB | N | N | IBRUTINIB | 100053847 |
| 10436181 | 10033117 | 1.61 | 59.7 | Palliative (P) | 2016-07-30 | 2016-08-28 | Capecitabine 35days + RT | 02 | N | CAPECITABINE | 101786544 |
| 10436182 | 10033118 | null | 63 | Curative (C) | 2016-06-10 | 2016-07-08 | Rituximab | 02 | N | RITUXIMAB | 100246538 |
| 10436186 | 10033119 | 1.59 | 62.8 | Adjuvant (A) | 2017-09-07 | 2017-09-07 | Capecitabine | 02 | N | CAPECITABINE | 100019535 |
| 10436187 | 10033120 | 1.86 | 90 | 03 | 2019-02-20 | 2019-03-01 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100176221 |
| 10436188 | 10033121 | 1.68 | null | Palliative (P) | 2019-08-06 | 2019-09-04 | Rituximab | 02 | N | RITUXIMAB | 101226632 |
| 10436189 | 10033122 | 1.88 | 100 | Palliative (P) | 2021-09-25 | 2021-09-26 | IBRUTINIB | 02 | N | IBRUTINIB | 101649225 |
| 10436199 | 10033123 | 1.69 | 68 | Palliative (P) | 2022-03-18 | 2022-03-25 | Capecitabine + Oxaliplatin 14day | 02 | N | DOCETAXEL | 101536473 |
| 10436225 | 10033124 | 1.72 | 58.5 | Palliative (P) | 2018-02-01 | 2018-02-04 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101350557 |
| 10436230 | 10033125 | 1.72 | 60 | Palliative (P) | 2015-10-02 | 2015-10-12 | Capecitabine | 02 | N | CAPECITABINE | 100564688 |
| 10436258 | 10033126 | 1.78 | 69.8 | Adjuvant (A) | null | 2019-06-25 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101486904 |
| 10436264 | 10033127 | 1.64 | 108.5 | Palliative (P) | 2017-02-28 | 2017-03-07 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100322572 |
| 10436268 | 10033128 | 1.76 | 77 | Palliative (P) | 2016-02-19 | 2016-03-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101232612 |
| 10436279 | 10033129 | 1.69 | 68.4 | Palliative (P) | null | 2016-03-19 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100324368 |
| 10436291 | 10033130 | 1.59 | 88.85 | Palliative (P) | 2019-11-08 | 2019-11-22 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101346974 |
| 10436296 | 10033131 | null | null | Adjuvant (A) | 2018-08-09 | 2018-08-09 | IBRUTINIB | 02 | N | IBRUTINIB | 100429645 |
| 10436301 | 10033132 | 1.77 | 77.1 | 02 | 2018-07-24 | 2018-07-26 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100015440 |
| 10436317 | 10033133 | 1.55 | 89.2 | null | 2019-08-08 | 2019-08-19 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 101005042 |
| 10436325 | 10033134 | 1.71 | 60.4 | Palliative (P) | 2020-01-16 | 2020-01-29 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 100695650 |
| 10436338 | 10033135 | 0 | 73.8 | Adjuvant (A) | 2019-03-28 | 2019-11-25 | IBRUTINIB | 02 | N | IBRUTINIB | 101674074 |
| 10436367 | 10033136 | 1.86 | 83 | Adjuvant (A) | 2022-03-12 | 2022-03-13 | Rituximab | 02 | N | RITUXIMAB | 100243298 |
| 10436385 | 10033137 | 1.86 | 115.8 | null | 2020-06-29 | 2020-07-30 | IBRUTINIB | 02 | null | PEMBROLIZUMAB | 100056029 |
| 10436397 | 10033138 | 1.64 | 59 | Neo-adjuvant (N) | 2018-09-21 | 2018-10-02 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100541734 |
| 10436398 | 10033139 | 1.63 | 122.7 | Adjuvant (A) | 2017-05-20 | 2017-05-29 | CHOP R | 99 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100870179 |
| 10436412 | 10033140 | 1.61 | 72.6 | Adjuvant (A) | 2018-01-03 | 2018-01-14 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100968826 |
| 10436415 | 10033141 | null | 91.6 | Palliative (P) | 2017-05-17 | 2017-05-23 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101510613 |
| 10436427 | 10033142 | 1.67 | 98.45 | 03 | 2020-09-09 | 2020-09-14 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100654142 |
| 10436451 | 10033143 | 1.81 | 69 | 03 | 2017-04-27 | 2017-05-23 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 100916956 |
| 10436455 | 10033144 | 1.74 | 81.5 | Palliative (P) | 2017-02-12 | 2017-02-27 | Capecitabine 35days + RT | 02 | N | CAPECITABINE | 100383917 |
| 10436474 | 10033146 | 1.51 | 41.2 | Neo-adjuvant (N) | 2018-05-17 | 2018-06-13 | IBRUTINIB | 02 | null | IBRUTINIB | 100902414 |
| 10436500 | 10033147 | 1.61 | null | null | 2022-03-09 | 2022-03-11 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100283636 |
| 10436501 | 10033148 | 1.83 | 65 | 03 | 2021-12-11 | 2021-12-24 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100901243 |
| 10436512 | 10033149 | 1.58 | 70.3 | Curative (C) | 2018-03-16 | 2018-04-27 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101664649 |
| 10436538 | 10033150 | 1.76 | 97 | Palliative (P) | 2020-08-12 | 2020-08-27 | Docetaxel | 02 | N | PEMBROLIZUMAB | 100520123 |